PATENT CLAIM ANALYSIS

Application Number: 16186769
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["514", "252010"]

Abstract:
Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof: Also disclosed herein are uses of a compound disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of a composition in the potential treatment or prevention of an IDO-associated disease or disorder.

Claim (Index 20):
The method of  claim 19 , wherein the cancer is selected from colon cancer, pancreas cancer, breast cancer, prostate cancer, lung cancer, brain cancer, ovary cancer, cervix cancer, testes cancer, renal cancer, head and neck cancer, lymphoma, leukemia, and melanoma.

Metadata:
- Claim Count in Document: 34.0
- Percentile: 98.0
- Lexical Diversity: 2.08571
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16061597', '13780510', '11641284', '13501633', '11430441']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.819527007123645
- 35 USC 102 Novelty (BERT): 0.5585969265992963
- Combined Prediction Score: 0.7934339990712101
- Mean Citation Score: 392.197194
- Max Citation Score: 435.63135
- Similarity Product: 346.9878602230757

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test